News | April 25, 2013

Philips Collaborates With Partners to Introduce Advanced MRI Clinical Functionalities

New clinical functionalities designed to transform care in MRI address the challenges of an aging population and economic pressures on health care providers

April 25, 2013 — At the International Society for Magnetic Resonance in Medicine’s (ISMRM) 21st Annual Meeting in Salt Lake City, Utah, Philips Healthcare demonstrated a range of clinical functionalities in magnetic resonance imaging (MRI).

An increasing global incidence of neuro and vascular disease across the world is a result of both aging populations and increasingly unhealthy lifestyles. Philips is working in close collaboration with clinicians and researchers from across the world to develop new clinical functionalities that support high quality, clinically relevant diagnostics, whilst also improving patient throughput.

“Increasingly, MRI is proving its worth as a quick and cost effective diagnostic tool for the management of a wide variety of conditions; from stroke and dementia to tumor disease and trauma,” commented Dr. Jeroen Hendrikse, University Medical Center Utrecht, department of radiology. “A great example of this is pCASL, a functionality we’ve developed in close collaboration with the team at Philips. Not only does pCASL provide the user with an accurate assessment of brain perfusion — without the need for external contrast agent, a contraindication for many patients with renal insufficiency — but it’s also quick, taking just a short amount of additional time to scan.”

Jeffrey Miller, M.D., pediatric neuroradiologist, Phoenix Children’s Hospital, Arizona, adds, “Having access to these functionalities (pCASL, SWIp, mDIXON TSE and mDIXON Quant) means that we’re able to detect injuries that may not be apparent using conventional techniques, which can ultimately mean a better outcome for our patients. In particular, we’re seeing a real benefit from the image quality provided by the time-efficient mDIXON TSE technique in challenging anatomies such as spine, as well as the lesion delineation it provides.”

The functionalities*, developed collaboratively, that are being showcased at ISMRM include:

  • pCASL (pseudo-Continuous Arterial Spin Labeling) — using arterial water as an endogenous tracer, pCASL provides cost effective and accurate assessment of changes in brain perfusion, without the need for contrast agent injection.
  • SWIp** (Susceptibility Weighted Imaging with Phase difference) — utilizing phase information to enhance susceptibility contrast between tissues and a multi-echo acquisition to provide high SNR (signal-to-noise ratio), SWIp can help in the diagnosis of various brain lesions such as hemorrhage or venous malformation.
  • mDIXON TSE — a fast two-point DIXON technique that robustly separates water and fat signals, allowing for time-efficient, large FOV (field-of-view) fat-free imaging even in challenging areas such as head, neck or spine, and providing four contrasts in one scan.
  • mDIXON Quant** — utilizing an mDIXON multi-gradient-echo technique and state-of-the-art reconstruction for fast, volumetric, fat fraction quantification mapping, targeting anatomies such as the liver.

The development of these latest functionalities is a direct result of the ongoing clinical collaborations, which Philips has in-place with leading clinicians and researchers, including with Hendrikse in Utrecht and Miller in Phoenix.

“As we continue to expand our MRI portfolio at Philips, our focus is to provide solutions that address the day-to-day needs of the radiology and clinical teams. Ultimately, innovation is only meaningful if it can bring about positive change for patients. Our commitment to achieving this is evident through our many and ongoing research collaborations,” commented Eric Jean, general manager, global MR, Philips Healthcare. “It really is exciting to see that this approach is instrumental in addressing some of the most significant challenges in MRI today.”

* New functionalities available now on Philips Ingenia system, and on all Philips MRI systems by end of 2013

** 510(k) pending. Not available for sale in USA

For more information: www.philips.com/ismrm

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
Ingenia Ambition X 1.5T MR. This innovation is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis
News | Magnetic Resonance Imaging (MRI) | September 14, 2018
Philips, a global leader in health technology, launched the Ingenia Ambition X 1.5T MR.
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | September 07, 2018 | By Sabine Sartoretti, M.D.
As soon as the Compressed SENSE technology became available to the MRI team at Kantonsspital Winterthur (Switzerland),...

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 06, 2018 | By Melinda Taschetta-Millane
According to the Prescient & Strategic Intelligence report, “Global Magnetic Resonance Imaging (MRI) Market Size,...
Brain Iron Levels May Predict Multiple Sclerosis Disabilities
News | Neuro Imaging | August 31, 2018
A new, highly accurate magnetic resonance imaging (MRI) technique can monitor iron levels in the brains of multiple...
Study Finds Multiple Sclerosis Drug Slows Brain Shrinkage

An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Image courtesy of Robert J. Fox, M.D., Cleveland Clinic.

News | Neuro Imaging | August 30, 2018
August 30, 2018 — Results from a clinical...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...
iSchemaView RAPID Technology Now Installed in More Than 500 Stroke Centers
News | Neuro Imaging | August 27, 2018
iSchemaView announced that more than 575 stroke centers in 22 countries have selected the RAPID advanced imaging...